BNF:

8.2.4

Status:

Red

Decision Date:

September 2014

Comments

RED:

• NICE TA320 - treatment option for adults with active relapsing-remitting multiple sclerosis.  (NHSE commissioned).  (Decision date - September 2014).                                                                                                                           
• NICE TA475: for treating moderate to severe plaque psoriasis. (ICB commissioned).  (Decision date - October 2017).

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again